Os Therapies Incorporated (OSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 03-2003 | 12-2002 | 09-2002 | |
| Gross Profit | N/A | N/A | 870 | 620 | 850 |
| Operating Expenses | 1,048 | 0 | 360 | 470 | 420 |
| Operating Income | -1,048 | N/A | -360 | -470 | -420 |
| Interest Expense | 799 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -1,847 | 0 | -360 | -470 | -420 |
| Net Income Continuous | -1,847 | N/A | -360 | -470 | -420 |
| Net Income | $-1,847 | $N/A | $-360 | $-470 | $-420 |
| EPS Basic Total Ops | -0.18 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -0.18 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.18 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -0.18 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-432 | $N/A | $-190 | $-280 | $-240 |